SCHEMBL5745283

SCHEMBL5745283

COc1cc2c(C(=O)O)cnc(C(=O)c3cccc(OCC(=O)NCCc4ccccc4)c3)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ PKM P14618 1/20 0.48
▸ LMNA P02545 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ VNN1 O95497 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ GFPT1 Q06210 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ ABCB1 P08183 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745432 0.84 LMNA (0.48) PTPN1SMN1; SMN2PKMLMNAKMT2A
SCHEMBL5745391 0.84 GFPT1 (0.49) KMT2AMEN1CYP1A2HSD17B10VNN1
SCHEMBL5745161 0.83 KMT2A (0.48) LMNAALDH1A1MAPTKMT2AMEN1
SCHEMBL5745387 0.82 RAB9A (0.50) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL5743070 0.82 VNN1 (0.49) SMN1; SMN2PKMCYP1A2NPC1VNN1
SCHEMBL5744347 0.82 VNN1 (0.49) SMN1; SMN2PKMCYP1A2NPC1VNN1
SCHEMBL5744619 0.81 GFPT1 (0.49) SMN1; SMN2LMNAALDH1A1MAPTKMT2A
SCHEMBL5743882 0.81 GFPT1 (0.49) CYP1A2NPC1KDM4EVNN1GFPT1
Trifluoroacetic Acid SCHEMBL5767994 0.80 GFPT1 (0.51) PTPN1PKMLMNACYP1A2KDM4E
SCHEMBL5746006 0.80 GFPT1 (0.47) LMNAMAPTKMT2ACYP1A2VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631551-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 — — EP claimed
WO-2004101528-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 — — WO claimed
EP-1631551-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 — — EP disclosed
WO-2004101528-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 — — WO disclosed
Send feedback